Alpha DNA Investment Management’s Marvell Technology MRVL Stock Holding History

Alpha DNA Investment Management’s Portfolio MRVL Stock Details MRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7,917	Closed	-$874K	–	109
2024 Q4	$874K	Buy	+7,917	New	+$735K	0.33%	61
2024 Q3	–	Sell	-11,251	Closed	-$786K	–	232
2024 Q2	$786K	Buy	+11,251	New	+$788K	0.31%	73
2022 Q3	–	Sell	-24,782	Closed	-$1.08M	–	182
2022 Q2	$1.08M	Buy	24,782 +5,549	+29%	+$315K	0.92%	32
2022 Q1	$1.38M	Buy	+19,233	New	+$1.39M	0.97%	28
2021 Q1	–	Sell	-194	Closed	-$9K	–	748
2020 Q4	$9K	Buy	+194	New	+$8.4K	0.01%	309

Other funds holding MRVL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Alpha DNA Investment Management's MRVL Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Marvell Technology (MRVL) in Q1 2025, closing a stake of 7,917 shares — an estimated $874K sold.

Alpha DNA Investment Management first reported a position in MRVL in Q4 2020 and held it in 5 quarters. The position peaked at $1.38M in Q1 2022. 1,235 funds tracked by Wall St. Rank hold MRVL as of Q1 2025.

Alpha DNA Investment Management reported no remaining Marvell Technology position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 7,917 Marvell Technology shares in Q1 2025, an estimated $874K.
Alpha DNA Investment Management first reported a position in Marvell Technology in Q4 2020 and held it in 5 quarters.
Alpha DNA Investment Management's Marvell Technology position peaked at $1.38M in Q1 2022.
1,235 funds tracked by Wall St. Rank held Marvell Technology as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.